CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients

Overview of attention for article published in Leukemia, February 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

patent: 4 patents

facebook: 1 Facebook page

Citations

dimensions_citation: 245 Dimensions

Readers on

mendeley: 154 Mendeley
citeulike: 1 CiteULike

Summary Patents Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Mayo Clinic Mayo Authors, 13 Oct 2014

CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients.